BETTER MEDICINE
FOR ALL.

We make drugs efficient through long-acting injectables.

Learn more

 
 
 
 

Fast expanding portfolio

Already 4 programs in Preclinical & Clinical

Our pipeline

LEAD FORMULATION RESEARCH

mdc-WWM
CONTRACEPTION
PARTNER: GATES FOUNDATION
mdc-ANG
CNS
PARTNERED
mdc-NVA
PAIN
mdc-GRT
ORGAN TRANSPLANT
mdc-DOM
UROLOGY

PRECLINICAL & CLINICAL DEVELOPMENT

mdc-IRM
SCHIZOPHRENIA
PARTNER: TEVA

mdc-IRM / Schizophrenia • Clinical Phase 3

mdc-TJK
Central Nervous System
PARTNER: TEVA

mdc-TJK / CNS • Preclinical & Regulatory

mdc-CWM
PAIN AND INFLAMMATION
PARTNER: AIC

mdc-CWM / Pain & Inflammation • Clinical Phase 2

mdc-CMV /
ANESTHESIA, PAIN
Internal

mdc-CMV / Anesthesia, Pain • Preclinical & Regulatory

As of May, 2019

IMPACT HEALTH

People

130+ people, all shareholders, driven to impact health

Who we are

Business model

Building a global pharma leader through long-acting injectables working with NGOs, Private Sector, and Academics

Our network

Technology

We’ve broken every barrier to enabling long-acting injectable adoption

BEPO®

Meet us

Our news

Meet us

8th annual international Global Health Care Conference

07/15/2019

Who’s attending?

Simon Bennett

Singapore

Reimbursement and Access 2019

08/13/2019

Who’s attending?

Marcel Herold

Philadelphia, US

Our news

MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)

Corporate

04/05/2019

MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management

Corporate

03/11/2019

Publication of the activity report and financial information for the first half-year (April – Sept. 2018)

Investors

12/03/2018

See all

 
 

Who we are

Who we are

Our strength is our people

MedinCell is operated by our talented employees who have come together from around the world to achieve our mission of Better Medicine for All.
Through purposeful innovation, we aim to improve the treatments available to patients. And we believe that everyone should have access to best-in-class medication, so we focus on making our products available regardless of local economic conditions. To ensure access, we work on both for-profit and non-profit projects, in collaboration with highly valued partners ranging from big pharmas to physicians, from biotech firms to academics and foundations. Most importantly, our partners share our values based on trust and transparency.

Who we are

Careers

CONTACT

  • This field is for validation purposes and should be left unchanged.